Published in EXCLI J on November 07, 2016
Liver cirrhosis. Lancet (2008) 6.11
Pathogenesis of liver fibrosis. Annu Rev Pathol (2011) 5.27
Synaptic plasticity: LTP and LTD. Curr Opin Neurobiol (1994) 3.36
Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One (2007) 2.80
Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol (2005) 1.86
Hepatic stellate cells and liver fibrosis. Compr Physiol (2013) 1.75
Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol (2011) 1.73
Mesenchymal stem cells. Cell Transplant (2011) 1.62
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun (2007) 1.52
Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. J Neurosci (2004) 1.51
Decreased astrocytic thrombospondin-1 secretion after chronic ammonia treatment reduces the level of synaptic proteins: in vitro and in vivo studies. J Neurochem (2014) 1.45
Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact (2011) 1.44
Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology (2007) 1.41
What do the basal ganglia do? A modeling perspective. Biol Cybern (2010) 1.32
Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation. Hepatology (2007) 1.30
Memory processes in classical conditioning. Neurosci Biobehav Rev (2004) 1.20
Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World J Gastroenterol (2012) 1.18
Hepatoprotective effect of ethanolic extract of Curcuma longa on thioacetamide induced liver cirrhosis in rats. BMC Complement Altern Med (2013) 1.18
Hematopoietic stem cell trafficking in liver injury. FASEB J (2005) 1.16
Insights into the role of dopamine receptor systems in learning and memory. Rev Neurosci (2007) 1.10
Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells (2014) 1.06
Deterioration of spatial learning performances in lipopolysaccharide-treated mice. Jpn J Pharmacol (2001) 1.03
Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev (2012) 1.02
Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model. Stem Cell Rev (2011) 1.00
Effects of extracellular matrixes and growth factors on the hepatic differentiation of human embryonic stem cells. Am J Physiol Gastrointest Liver Physiol (2008) 1.00
Stem cells for liver tissue repair: current knowledge and perspectives. World J Gastroenterol (2008) 0.99
Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue. Differentiation (2010) 0.98
Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sci (2009) 0.97
Evaluation of oxidative stress based on lipid hydroperoxide, vitamin C and vitamin E during apoptosis and necrosis caused by thioacetamide in rat liver. Biochim Biophys Acta (2000) 0.96
NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-β1/Smad pathway and altering the MMP2/TIMP2 ratio in rats. PLoS One (2011) 0.95
Mesenchymal stem cells relieve fibrosis of Schistosoma japonicum-induced mouse liver injury. Exp Biol Med (Maywood) (2012) 0.94
Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease. Stem Cell Res Ther (2014) 0.90
Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. Liver Int (2013) 0.90
A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job. BioDrugs (2013) 0.89
A current review of the diagnostic and treatment strategies of hepatic encephalopathy. Int J Hepatol (2012) 0.88
Biostatistics 103: qualitative data - tests of independence. Singapore Med J (2003) 0.88
Loss of expression of glial fibrillary acidic protein in acute hyperammonemia. Neurochem Int (2002) 0.87
Transplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral stroke. BMC Neurosci (2010) 0.87
Treadmill exercise induces hippocampal astroglial alterations in rats. Neural Plast (2013) 0.87
Cerebral metabolic and histological effects of thioacetamide-induced liver failure. Am J Physiol (1993) 0.86
Hepatogenic differentiation of mesenchymal stem cells in a rat model of thioacetamide-induced liver cirrhosis. Cell Biol Int (2012) 0.86
On the neural substrates for exploratory dynamics in basal ganglia: a model. Neural Netw (2012) 0.86
Differential expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in thioacetamide-induced chronic liver injury. J Korean Med Sci (2010) 0.85
Biostatistics 102: quantitative data--parametric & non-parametric tests. Singapore Med J (2003) 0.85
Liver transplantation in acute alcoholic hepatitis: Current status and future development. World J Hepatol (2011) 0.84
Virus-related liver cirrhosis: molecular basis and therapeutic options. World J Gastroenterol (2014) 0.83
Inhibition of hepatic stellate cells proliferation by mesenchymal stem cells and the possible mechanisms. Hepatol Res (2009) 0.81
Behavioral and physiological sex differences observed in an animal model of fulminant hepatic encephalopathy in the rat. Physiol Behav (1997) 0.79
Impairment of the organization of locomotor and exploratory behaviors in bile duct-ligated rats. PLoS One (2012) 0.79
Effects of CA1 glutamatergic systems upon memory impairments in cholestatic rats. Behav Brain Res (2013) 0.79
The decrease of serum MMP-2 activity corresponds to alcoholic cirrhosis stage. Alcohol (2011) 0.78
Outcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis. World J Gastroenterol (2014) 0.78
Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice. Psychopharmacology (Berl) (2013) 0.77
Anxiety caused by traumatic brain injury correlates to decreased prefrontal cortex VEGF immunoreactivity and neuron density in immature rats. Turk Neurosurg (2012) 0.77
Effects of dopamine receptor agonist and antagonists on cholestasis-induced anxiolytic-like behaviors in rats. Eur J Pharmacol (2013) 0.77
Deficit of astroglia-derived thrombospondin-1 and loss of synaptic proteins in hepatic encephalopathy: do ammonia-overexposed astrocytes derange the synaptic hardware? J Neurochem (2014) 0.76